Join
Live feed
·
PRReleasevia Quantisnow
OPKO Health Inc. logo

OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

ByQuantisnow·Wall Street's wire, on your screen.
OPK· OPKO Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPK (OPKO Health Inc.) and more on Quantisnow.